ICOTD Projected Dividend Yield
Satellos Bioscience Inc ( OTCBB : ICOTD )Satellos Bioscience is engaged in the identification, development and commercialization of drug candidates with a clinical history and redoses, reformulates and develops these drug candidates to treat ocular and infectious diseases. Co. has two in-licensed products, which are in clinical development: iCo-008 for use in eotaxin-1 mediated indications; and an oral Amphotericin B delivery system for fungal infections. 21 YEAR PERFORMANCE RESULTS |
ICOTD Dividend History Detail ICOTD Dividend News ICOTD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |